Preoperative Molecular Markers in Thyroid Nodules

The need for distinguishing benign from malignant thyroid nodules has led to the pursuit of differentiating molecular markers. The most common molecular tests in clinical use are Afirma(®) Gene Expression Classifier (GEC) and Thyroseq(®) V2. Despite the rapidly developing field of molecular markers,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahli, Zeyad T., Smith, Philip W., Umbricht, Christopher B., Zeiger, Martha A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915469/
https://www.ncbi.nlm.nih.gov/pubmed/29720964
http://dx.doi.org/10.3389/fendo.2018.00179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915469/
https://www.ncbi.nlm.nih.gov/pubmed/29720964
http://dx.doi.org/10.3389/fendo.2018.00179

Ejemplares similares